摘要
对正常人、各种非癌性肝病患者血清α—Ｌ—岩藻糖苷酶及血清谷丙转氨酶进行了测定。结果显示，１４例重症肝炎、１０例急性黄疸性肝炎、９例慢性活动性肝炎、７例慢性迁延性肝炎和１５例肝硬化患者αＦＵ明显高于正常对照组（Ｐ＜００５）。慢性迁延性肝炎与正常对照组无统计学差异（Ｐ＞００５）。全部肝病患者血清αＦＵ与ＳＧＰＴ呈明显正相关（γ＝０６３，Ｐ＜００５）。结果表明αＦＵ并非原发性肝癌的特异性指标，在非癌性肝病中可有不同程度的升高。
This study examined serum α-l-fucosidase and SGPT activities in 33 normal subjects and in cases of 14 severe hepatitis、10 acute jaundice hepatitis、9 chronic active hepatitis、7 chronic persistent hepatitis and 15 liver cirrhosis.Except chronic persisting hepatitis,the other values of αFU were significantly higher than those of normal subjects(P<005).When all cases were taken into consideration,positive correlations were found between αFU and SGPT(γ=063,P<005).This results suggest that serum αFU activities increase not only in primary hepatic carcinoma but also in noncanerous diseases of the liver.
